Crossmark

Efficacy of recombinant erythropoietin for the late treatment of anemia of prematurity in a level IV neonatal intensive care unit: a retrospective single-center cohort study

Crossref DOI link: https://doi.org/10.1038/s41372-024-02001-6

Published Online: 2024-05-21

Published Print: 2024-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Connolly, Jillian M. https://orcid.org/0000-0002-8901-9319
McClary, Jacquelyn D.

Desai, Riddhi

Sundaram, Anupama

Neudecker, Mandy

Nock, Mary L. https://orcid.org/0000-0001-8451-7979
Ryan, Rita M. https://orcid.org/0000-0002-4588-3412
Marasch, Jaime L. https://orcid.org/0000-0002-4357-0308
License Information

Text and Data Mining valid from 2024-05-21

Version of Record valid from 2024-05-21
More Information

Article History

Received: 6 March 2024

Revised: 30 April 2024

Accepted: 7 May 2024

First Online: 21 May 2024

Competing interests

: The authors declare no competing interests.

: The protocol for this study was approved by the University Hospitals institutional review board. The need for informed consent was waived due to the retrospective nature of the study. This study was performed in accordance with the Declaration of Helsinki.

Document is current

Any future updates will be listed below